Results 1 to 10 of about 1,599,346 (327)

Solid pseudopapillary neoplasm of the pancreas after living-donor liver transplantation [PDF]

open access: yesJournal of Pediatric Surgery Case Reports, 2023
Background: Solid pseudopapillary neoplasm of the pancreas has been classified by the World Health Organization as a low-grade malignant tumor with potential to metastasize. The standard treatment for this neoplasm is complete surgical resection. However,
Norio Kawamura   +2 more
exaly   +4 more sources

Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement [PDF]

open access: yesLeukemia Research Reports, 2019
A 62-year-old male was diagnosed with blastic plasmacytoid dendritic cell neoplasm (BPDCN) with a MYC rearrangement. Four months after the first unrelated bone marrow transplantation (BMT), he developed the relapsed BPDCN.
Masataka Taguchi   +2 more
exaly   +5 more sources

Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation [PDF]

open access: yesBiology of Blood and Marrow Transplantation, 2013
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an exceedingly rare disorder categorized under acute myeloid leukemia by the World Health Organization.
Mehdi Hamadani, Mohamed Kharfan-Dabaja
exaly   +5 more sources

Neoplasm Transplantation Inhibition by Uninvolved Lymph Tissue [PDF]

open access: yesNature, 1966
HETEROLOGOUS transplantation of human neoplasms into the cheek pouch of the syrian hamster (Mesocricetus auratus) was first reported in 1951 (ref. 1). The uniqueness of the pouch as a site for transplantation results from the alymphatic structure and the very slow diffusion of large molecules out of the pouch area2.
B V, Caldwell, P A, Wright
openaire   +3 more sources

Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT [PDF]

open access: yesBone Marrow Transplantation, 2022
Allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative treatment for patients with myeloid/lymphoid neoplasm (MLN) with FGFR1 rearrangement, but data on overall results are limited.
J. Hernández-Boluda   +24 more
semanticscholar   +2 more sources

Allogeneic Hematopoietic Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) [PDF]

open access: yesBone Marrow Transplantation, 2021
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive hematological malignancy; however, some patients achieve durable remission with allogeneic hematopoietic cell transplantation (allo-HCT).
Q. Bashir   +19 more
semanticscholar   +3 more sources

Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report [PDF]

open access: yesClinical and Molecular Hepatology, 2018
Hepatic hemangioma represents the most common benign primary hepatic neoplasm. Although most such tumors are small and asymptomatic, giant hepatic hemangioma is frequently symptomatic, and requires intervention.
Ju Hyun Lee   +8 more
doaj   +2 more sources

Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia

open access: yesHaematologica, 2016
Acute myeloid leukemia is a clonal neoplasm derived from myeloid progenitor cells with a varying outcome. The initial goal of treatment is the achievement of complete remission, defined for over 40 years by morphology.
Gert J. Ossenkoppele   +2 more
doaj   +2 more sources

Recurrent facial microcystic adnexal carcinoma and hair transplantation on scar site

open access: yesClinical Case Reports, 2023
Key Clinical Message Microcystic adnexal carcinoma (MAC) is a rare kind of cutaneous neoplasm with a very aggressive local infiltration that destructs the affected tissues.
Amir Mohammad Beyzaee   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy